The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome

Vet J. 2011 Jun;188(3):260-9. doi: 10.1016/j.tvjl.2010.03.022. Epub 2010 Apr 24.

Abstract

Feline immunodeficiency virus (FIV), like human immunodeficiency virus (HIV)-1, is a neurotropic lentivirus, and both natural and experimental infections are associated with neuropathology. FIV enters the brain early following experimental infection, most likely via the blood-brain and blood-cerebrospinal fluid barriers. The exact mechanism of entry, and the factors that influence this entry, are not fully understood. As FIV is a recognised model of HIV-1 infection, understanding such mechanisms is important, particularly as HIV enters the brain early in infection. Furthermore, the development of strategies to combat this central nervous system (CNS) infection requires an understanding of the interactions between the virus and the CNS. In this review the results of both in vitro and in vivo FIV studies are assessed in an attempt to elucidate the mechanisms of viral entry into the brain.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Blood-Brain Barrier
  • Brain / virology*
  • Cats
  • Disease Models, Animal
  • Feline Acquired Immunodeficiency Syndrome / virology*
  • HIV Infections
  • HIV-1*
  • Humans
  • Immunodeficiency Virus, Feline / pathogenicity*